“It is rewarding to work in a space that is starving for innovation... The [IRRAS] team is scrappy and extraordinarily capable and it’s both fun and a privilege to work, squabble, & celebrate alongside them all.” - Val, Director, Operations

A day of remembrance, reflection, and continued commitment. #Juneteenth

“I chose to pursue biomedical engineering because I wanted a career where I could make a real difference and feel passionate about the work I do, and IRRAS has given me exactly that.” - Analie, Senior Medical Device Engineer

Join us at the 2025 #ACESociety Annual Meeting - happening Saturday, August 2, at the Charleston Marriott! From evolving clinical trial strategies to breakthroughs in fluid exchange, we’re diving into the science driving innovation. Register: lnkd.in/gghHXyQu

These data are remarkable! Fewer complications, reduced infections, lower shunt dependence, and improved functional outcomes compared to traditional EVD.journals.lww.com/neurosurgery/a… #IRRAflowfirst Nicholas Brandmeir Behnam Rezai Jahromi MD, PhD Adnan H. Siddiqui, MD CNS

Say goodbye to stylet entrapment and full catheter replacements. Say hello to a catheter designed for precision, security and ease. This is innovation designed with the customer in mind.

Excited to share this work from WVU, Adnan H. Siddiqui, MD, Alexandra Paul, and Behnam Rezai Jahromi MD, PhD, published online in Neurosurgery Publications, showing the benefits of Active CSF Exchange over traditional EVD for IVH, SAH, and ventriculitis. pubmed.ncbi.nlm.nih.gov/40548731/

Active Cerebrospinal Fluid Exchange vs External Ventricular Drainage in the Neurocritical Care Unit: An International, Retrospective Cohort Study 5 Key Points 📌: 1.🧠 Fewer Complications: ACE therapy using the IRRAflow catheter showed significantly fewer complications (like

It’s your LAST CHANCE to register for the 2025 Ace Society Annual Meeting! Join us on Saturday, August 2nd as neurosurgeons and clinical experts unite to advance neurocritical care. Dive into the science driving innovation and register for your spot: lnkd.in/gghHXyQu

Active Fluid Exchange – what is it? The IRRAflow system was built around that concept. Washing any pathological extracellular fluid collection is more effective than gravity-reliant drainage alone. The clinical data speaks for itself – visit irraflow.com.

You inspire us to innovate continually. We are excited to highlight the next gen. IRRAflow Dual-Lumen Catheter (ICAT 030)! The new catheter is designed with an emphasis on application, enhanced control and the elevation of patient care. Learn more at irraflow.com

Real patient stories. Real impact. Discover IRRAflow patient stories on our NEW Patient Education Website: hopeafterhemorrhage.com

Are you following us on Instagram? Featuring #IRRAflowFamily shoutouts, sneak peeks into life in the field and more, our Instagram account is just a glimpse into the faces and facilities utilizing IRRAflow. Follow us @irras_neuro to stay up-to-date with all things IRRAflow!

Wishing everyone a safe and happy Fourth of July from all of us at IRRAS.

Less reoperations = better patient outcomes. #IRRAflow in TDC-FIT reduces cSDH recurrence to 6.3% vs. 34.1% in standard care, even for high-risk patients. Read more at irraflow.com/resources/clin…

Big questions. Bold ideas. Real collaboration. Join leading neurosurgeons and innovators at the 2025 Active Cerebrospinal Fluid Exchange Society (ACE) Annual Meeting in Charleston on Saturday, August 2. linkedin.com/company/active…

Retrospective study, Neurosurgery, 2024 | N = 519 IRRAflow (ACE) vs. EVD outcomes: Failure to drain: 4.2% vs. 17.2% Infection: 5.9% vs. 24.4% CSF leak: 2.5% vs. 9.2% MRS 0–2 at discharge: 22.1% vs. 10.3% Read more: irraflow.com/wp-content/upl…

Join us at SNIS 2025 in Nashville, TN from July 14-18 – reach out to your IRRAS representative today to schedule time with our team members. We look forward to engaging conversations with the brightest minds in NeuroInterventional Surgery. SNIS Info

A newly published study found complications in 10% of an IRRAflow-treated TDC-FIT group of patients vs. 56.7% in a craniotomy group. Discover more about the benefits of pressure-controlled fibrinolytic irrigation therapy here: irraflow.com/wp-content/upl…

ICAT 030 – resolving placement challenges, enhancing control & elevating care. Inquire now to be amongst the first to utilize the next-gen IRRAflow catheter in your practice. irraflow.com